Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Innometry Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Lee Gapsoo

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführerno data
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managementskeine Daten
Durchschnittliche Amtszeit der Vorstandsmitgliederkeine Daten

Jüngste Management Updates

Keine Aktualisierungen

Recent updates

There May Be Underlying Issues With The Quality Of Innometry's (KOSDAQ:302430) Earnings

Mar 27
There May Be Underlying Issues With The Quality Of Innometry's (KOSDAQ:302430) Earnings

What Innometry Co., Ltd.'s (KOSDAQ:302430) 29% Share Price Gain Is Not Telling You

Mar 08
What Innometry Co., Ltd.'s (KOSDAQ:302430) 29% Share Price Gain Is Not Telling You

The Innometry (KOSDAQ:302430) Share Price Has Gained 34% And Shareholders Are Hoping For More

Mar 10
The Innometry (KOSDAQ:302430) Share Price Has Gained 34% And Shareholders Are Hoping For More

What Kind Of Investors Own Most Of Innometry Co., Ltd. (KOSDAQ:302430)?

Feb 19
What Kind Of Investors Own Most Of Innometry Co., Ltd. (KOSDAQ:302430)?

Innometry Co., Ltd. (KOSDAQ:302430) On An Uptrend: Could Fundamentals Be Driving The Stock?

Feb 04
Innometry Co., Ltd. (KOSDAQ:302430) On An Uptrend: Could Fundamentals Be Driving The Stock?

Tread With Caution Around Innometry Co., Ltd.'s (KOSDAQ:302430) 1.7% Dividend Yield

Jan 20
Tread With Caution Around Innometry Co., Ltd.'s (KOSDAQ:302430) 1.7% Dividend Yield

Should You Be Impressed By Innometry's (KOSDAQ:302430) Returns on Capital?

Jan 01
Should You Be Impressed By Innometry's (KOSDAQ:302430) Returns on Capital?

Innometry's (KOSDAQ:302430) Earnings Are Growing But Is There More To The Story?

Dec 17
Innometry's (KOSDAQ:302430) Earnings Are Growing But Is There More To The Story?

Did Innometry's (KOSDAQ:302430) Share Price Deserve to Gain 38%?

Dec 02
Did Innometry's (KOSDAQ:302430) Share Price Deserve to Gain 38%?

Geschäftsführer

Lee Gapsoo

no data

Amtszeit

Lee Gapsoo serves as Chief Executive Officer of Innometry Co., Ltd.